8-K: Herbalife Reports Q2 Sales Growth, CFO Transition

Herbalife announced second quarter 2026 net sales growth of 5.4% year-over-year, exceeding guidance on a constant currency basis, alongside the planned retirement of CFO John DeSimone and the appointment of Scott Schaefer.

Summary

• Herbalife reported $1.3 billion in net sales for the second quarter of 2026, a 5.4% increase year-over-year, or 5.8% on a constant currency basis, marking the fourth consecutive quarter of topline expansion.
• The company reported a net loss of $26.3 million, primarily due to a $94.6 million loss on extinguishment of debt from an April 2026 refinancing.
• Adjusted EBITDA was $166.6 million, or $174.4 million on a constant currency basis, exceeding guidance.
• John DeSimone, the Chief Financial Officer, will retire effective December 31, 2026, and Scott Schaefer will succeed him starting January 1, 2027.
• New product launches include Bioniq GO, a personalized nutrition product, and two new Life I/O products: Helio and Activate Energy.
• The company provided guidance for the third quarter and revised its full-year 2026 outlook, narrowing the Adjusted EBITDA range to $670 million to $690 million.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive report, with net sales growth and exceeding guidance on a constant currency basis, offset by FX headwinds and a net loss due to debt extinguishment.

Positives

• Achieved net sales of $1.3 billion, up 5.4% year-over-year, and 5.8% on a constant currency basis, exceeding guidance.
• Represents the fourth consecutive quarter of year-over-year net sales growth on both reported and constant currency bases.
• Adjusted EBITDA of $166.6 million (or $174.4 million on a constant currency basis) was toward the upper end of guidance and exceeded guidance on a constant currency basis.
• Launched Bioniq GO, a next-generation personalized product, in eleven EMEA markets and North America, with subscription options available.
• Introduced two new products under the Life I/O brand: Helio and Activate Energy.
• Strong distributor engagement with over 110,000 attendees at 2026 Extravaganza events globally.
• Successfully refinanced debt in April 2026.

Negatives

• Reported a net loss attributable to Herbalife of $26.3 million for the quarter.
• Incurred a significant loss on extinguishment of debt of $94.6 million.
• Gross profit margin decreased slightly to 77.7% from 78.0% year-over-year, attributed to sales mix pressure, higher other costs, and inventory write-downs, partially offset by pricing benefits.
• Adjusted EBITDA margin decreased by 120 basis points year-over-year.
• Full-year 2026 Adjusted EBITDA guidance range was narrowed, primarily reflecting FX headwinds, although constant currency guidance was raised.

Risks

• Unfavorable foreign exchange rate fluctuations are impacting reported results and outlook.
• Potential impacts of current global economic conditions, including inflation.
• Risks associated with operating internationally, particularly in China.
• Legal and regulatory matters, including regulatory actions concerning products or the network marketing program, and product liability claims.
• The Consent Order with the Federal Trade Commission (FTC) and any failure to comply therewith.
• Adverse publicity associated with the Company or the direct-selling industry.
• Changing consumer preferences and demands and evolving industry standards.
• Reliance on senior management and potential departure of key personnel.

Future Outlook

For the third quarter of 2026, the company guides for net sales growth of +0.5% to +4.5% (reported) and +1.5% to +5.5% (constant currency), with Adjusted EBITDA between $160-$180 million (reported) and $165-$185 million (constant currency). For the full year 2026, net sales guidance is +2.5% to +5.5% (reported), and Adjusted EBITDA guidance is narrowed to $670 million to $690 million, primarily due to FX headwinds, though constant currency guidance was raised.

Management Comments

• "Our net sales and EBITDA results for the second quarter were at the high end of previously issued guidance," said John DeSimone, Chief Financial Officer.
• "While the recent strengthening of the U.S. dollar has resulted in additional foreign exchange headwinds affecting our reported outlook for the back half of the year, our constant currency outlook remains consistent with the expectations we shared last quarter."
• "We delivered a fourth consecutive quarter of year-over-year net sales growth, and we continue to expect net sales growth for the remainder of the year," said Stephan Gratziani.
• "This momentum reflects the resilience of Herbalife and has us poised to successfully carry out our long-term growth strategy."
• "John DeSimone played an impactful role in laying this foundation, and I am grateful to him for his leadership and partnership."
• "I am confident Scott Schaefer's financial expertise and strategic perspective will help propel us in our next chapter."

Industry Context

StockSavvy.ai notes that Herbalife's continued net sales growth, even with FX headwinds, aligns with broader trends in the health and wellness sector, particularly the increasing consumer interest in personalized nutrition and convenient product formats. The company's focus on digital platforms and direct-to-consumer engagement through its distributor network is a key strategy in this evolving market.

Management Changes

Stakeholder Impact

• Shareholders: The report shows continued sales growth but also a net loss and FX headwinds, which may influence investor sentiment. The CFO transition is a key leadership change to monitor.
• Distributors: Continued investment in platforms like Pro2colTM and new product launches like Bioniq GO aim to support distributor success and engagement.
• Customers: Introduction of new personalized nutrition products (Bioniq GO) and healthy lifespan products (Helio, Activate Energy) offer new options for consumers.
• Creditors: The company successfully refinanced debt in April 2026, and the reported leverage ratios (Credit Agreement Total Leverage Ratio of 2.7x and Net Leverage Ratio of 2.2x as of June 30, 2026) should be monitored.

Next Steps

• Continue to monitor foreign exchange headwinds and their impact on reported results.
• Execute on the launch and expansion of Bioniq GO and other new products.
• Further develop and integrate the Pro2colTM platform and at-home blood test diagnostics.
• Implement the transition of Chief Financial Officer responsibilities from John DeSimone to Scott Schaefer.
• Continue to engage distributors and consumers through global events and marketing campaigns.

Key Dates

Recommendation

The report shows positive trends in net sales growth and constant currency performance, exceeding guidance in key areas. However, the net loss due to debt extinguishment, ongoing FX headwinds, and the significant CFO transition introduce uncertainties that warrant a cautious 'hold' stance until the impact of these factors becomes clearer.

Keywords

Herbalife, Nutrition, Direct Selling, Financial Results, Personalized Nutrition, CFO Transition, Net Sales, Adjusted EBITDA